Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human factor XIII (composed of two A subunits)

EU orphan designation number: EU/3/03/179
Active ingredient: Recombinant human factor XIII (composed of two A subunits)
Indication: Treatment of hereditary factor XIII deficiency
Sponsor: Novo Nordisk A/S
Novo Allé, 2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2003 Orphan designation EMEA/OD/052/03 (2003)5037 of 12/12/2003
19/01/2005 Transfer of orphan designation EMEA/OD/052/03/T/01 (2004)5468 of 30/12/2004
23/07/2012 Removal of orphan designation from Community Register